Ítem
Solo Metadatos

Using PICO Methodology to Answer Questions About Smoking in COPD Patients

Mostrar el registro sencillo de la publicación
dc.creatorJiménez Ruiz C.A.spa
dc.creatorBuljubasich D.spa
dc.creatorRiesco Miranda J.A.spa
dc.creatorAcuña Izcaray A.spa
dc.creatorde Granda Orive J.I.spa
dc.creatorChatkin J.M.spa
dc.creatorZabert G.spa
dc.creatorGuerreros Benavides A.spa
dc.creatorPaez Espinel N.spa
dc.creatorNoé V.spa
dc.creatorSánchez-Angarita E.spa
dc.creatorNúñez-Sánchez I.spa
dc.creatorSansores R.H.spa
dc.creatorCasas A.spa
dc.creatorPalomar Lever A.spa
dc.creatorAlfageme Michavila I.spa
dc.date.accessioned2020-05-25T23:58:21Z
dc.date.available2020-05-25T23:58:21Z
dc.date.created2017spa
dc.description.abstractThe ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i) moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii) high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii) high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv) high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics. © 2017 SEPAReng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/j.arbres.2017.04.012
dc.identifier.issn3002896
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/22844
dc.language.isoengspa
dc.publisherElsevier Doymaspa
dc.relation.citationEndPage628
dc.relation.citationIssueNo. 11
dc.relation.citationStartPage622
dc.relation.citationTitleArchivos de Bronconeumologia
dc.relation.citationVolumeVol. 53
dc.relation.ispartofArchivos de Bronconeumologia, ISSN:3002896, Vol.53, No.11 (2017); pp. 622-628spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044788291&doi=10.1016%2fj.arbres.2017.04.012&partnerID=40&md5=1a73c119424c3fc87652814daeea1b5espa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordArticlespa
dc.subject.keywordChronic obstructive lung diseasespa
dc.subject.keywordCounselingspa
dc.subject.keywordHigh risk patientspa
dc.subject.keywordHospital dischargespa
dc.subject.keywordHospitalizationspa
dc.subject.keywordHumanspa
dc.subject.keywordSmokingspa
dc.subject.keywordSmoking cessationspa
dc.subject.keywordSpirometryspa
dc.subject.keywordAgespa
dc.subject.keywordHealth economicsspa
dc.subject.keywordHigh risk populationspa
dc.subject.keywordSmoking habitspa
dc.subject.keywordChronic obstructive lung diseasespa
dc.subject.keywordClinical trial (topic)spa
dc.subject.keywordCost benefit analysisspa
dc.subject.keywordDrug therapyspa
dc.subject.keywordEconomicsspa
dc.subject.keywordEvidence based medicinespa
dc.subject.keywordMotivationspa
dc.subject.keywordPathophysiologyspa
dc.subject.keywordProceduresspa
dc.subject.keywordPsychologyspa
dc.subject.keywordQuestionnairespa
dc.subject.keywordRandomized controlled trial (topic)spa
dc.subject.keywordSmokingspa
dc.subject.keywordTherapyspa
dc.subject.keywordAmfebutamonespa
dc.subject.keywordBiological markerspa
dc.subject.keywordNicotinespa
dc.subject.keywordNicotinic agentspa
dc.subject.keywordVareniclinespa
dc.subject.keywordBiomarkersspa
dc.subject.keywordBupropionspa
dc.subject.keywordClinical Trials as Topicspa
dc.subject.keywordCost-Benefit Analysisspa
dc.subject.keywordCounselingspa
dc.subject.keywordEvidence-Based Medicinespa
dc.subject.keywordHumansspa
dc.subject.keywordMotivationspa
dc.subject.keywordNicotinespa
dc.subject.keywordNicotinic Agonistsspa
dc.subject.keywordPulmonary Diseaseeng
dc.subject.keywordRandomized Controlled Trials as Topicspa
dc.subject.keywordSmokingspa
dc.subject.keywordSmoking Cessationspa
dc.subject.keywordSpirometryspa
dc.subject.keywordSurveys and Questionnairesspa
dc.subject.keywordVareniclinespa
dc.subject.keywordChronic obstructive pulmonary diseasespa
dc.subject.keywordSmokingspa
dc.subject.keywordSpirometryspa
dc.subject.keywordTreatmentspa
dc.titleUsing PICO Methodology to Answer Questions About Smoking in COPD Patientsspa
dc.title.TranslatedTitlePreguntas y respuestas relacionadas con tabaquismo en pacientes con EPOC. Aplicación de metodología con formato PICOspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos